The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
What's New at
  • Email Email
  • Glossary Glossary


IAS and WHO Identify the Most Critical Research Needs for Infants, Children and Adolescents Living With HIV

World Health Organization; Posted Jul 24, 2:18 p.m. ET

The most pressing gaps in research needed to improve outcomes for children and adolescents living with HIV are highlighted in the first global priority research agendas on paediatric and adolescent HIV.

Mystifying Cochrane Library Review on HCV Therapy Elicits Strong Response from IDSA

Paul E. Sax, M.D., Journal Watch; Posted Jul 24, 1:24 p.m. ET

"Last month, the Cochrane Review published a controversial paper on HCV therapy that left many ID doctors and hepatologists perplexed," writes Paul Sax, M.D.

19.5 Million People Now on Life-Saving HIV Treatment

amfAR, The Foundation for AIDS Research; Posted Jul 24, 12:52 p.m. ET

UNAIDS has announced that for the first time, more than half of all people living with HIV (53%) have access to treatment, and that AIDS-related deaths have declined by almost half since 2005.

Know Your Drugs and Classes of HCV Treatment

Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Jul 24, 12:12 p.m. ET

There are several emerging treatments for hepatitis C virus. Here is a brief guide to some drugs and the classes to which they belong.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?

Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?


Case of HIV Remission in South African Child

Warren Tong,; Posted Jul 24, 9:20 a.m. ET

After very early antiretroviral therapy during infancy, a HIV-positive child in South Africa has been able to control the virus without any meds for eight and a half years, according to a study presented at IAS 2017.

Isentress HD: A New Once-Daily Formulation of Raltegravir Approved in Canada

Sean R. Hosein,; Posted Jul 21, 12:50 p.m. ET

In late June 2017, Health Canada licensed the sale and use of a new formulation of the anti-HIV drug raltegravir (Isentress) as part of the treatment of HIV.

This Week in HIV Research: Effect of Viral Load Perception on Sex, and HIV Prevention Options Needed in U.S. Prisons

Warren Tong and Barbara Jungwirth,; Posted Jul 21, 12:40 p.m. ET

This week, a study finds that viral load perception may change sexual behaviors among HIV-positive men who have sex with men.

Vosevi: Frequently Asked Questions

Project Inform; Posted Jul 21, 12:25 p.m. ET

These frequently asked questions will help you understand what Vosevi is, how it works, and help you decide if it is the right hepatitis C medication for you.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.


Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention

AVAC: Global Advocacy for HIV Prevention; Posted Jul 21, 11:35 a.m. ET

A new report documents 2016 funding and highlights a continuing trend of flat or declining funding and its potential impact on further innovation in HIV prevention research and development.

FDA Approves Vosevi for Hepatitis C

U.S. Food and Drug Administration; Posted Jul 20, 8:58 p.m. ET

"Vosevi provides a treatment option for some patients who were not successfully treated with other HCV drugs in the past."

Who's Most at Risk of Getting Kaposi Sarcoma? New Research Gives Insights

Emily Newman, BETA; Posted Jul 20, 4:23 p.m. ET

People who had low recent CD4 counts, high recent viral loads, or who had higher average viral loads over time had the highest risk of developing Kaposi sarcoma, according to a study published this month in JAIDS.

Depression and Anxiety Not Barriers to HCV Treatment Success

Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Jul 20, 3:38 p.m. ET

Researchers in San Diego, Calif., said that having both "mental health and substance diagnoses" was not a barrier to successful HCV treatment.

>> Browse Older Featured Stories


  • Email Email
  • Glossary Glossary